Enter assignee name

Forward Citations = 3

Loading Chart...

3 inventors (with patents filed for the assignee):

Peter Blackburn (6 out of 20 patents)

Stephen Grimes (5 out of 7 patents)

Tihamer Orban (1 out of 4 patents)

6 patents: Sort by Forward Citations

1. 12370251 - Adjuvanted nanoparticulate influenza vaccine (2025-07-29),

2. 11419924 - Immunotherapeutic compositions for the treatment of Alzheimer's disease (2022-08-23),

3. 11110155 - Immunotherapeutic compositions for the treatment of Alzheimer's disease (2021-09-07),

4. 10716836 - Methods for treating autoimmune disease by inducing autoantigen-specific regulatory CD4+ T cells (2020-07-21),

5. 10335468 - Immunotherapeutic compositions for the treatment of alzheimer's disease (2019-07-02),

6. 9498522 - Immunotherapeutic compositions for the treatment of alzheimer'S disease (2016-11-22),

Mercia Pharma, Inc. is a leading pharmaceutical company focused on developing and delivering innovative healthcare solutions to improve patients' quality of life. With a commitment to research and development, Mercia Pharma aims to address critical unmet medical needs and drive advancements in healthcare. The company's portfolio includes a range of products in various therapeutic areas, designed to meet the needs of patients worldwide.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

6 Patents

#947 in New York, NY

#2,570 in New York

#43,823 in US

New York, NY, United States of America

Mercia Pharma, Inc.

Forward Citations = 3

3 inventors:

Peter Blackburn (6 out of 20 patents)

Stephen Grimes (5 out of 7 patents)

Tihamer Orban (1 out of 4 patents)

Please report any incorrect information to support@idiyas.com